Cavalli M - Search Results

1

Fatty Acid-Derived Pro-Toxicants of the Rat Selective Toxicant Norbormide.

Choi H, Conole D, Atkinson DJ, Laita O, Jay-Smith M, Pagano MA, Ribaudo G, Cavalli M, Bova S, Hopkins B, Brimble MA, Rennison D. Choi H, et al. Among authors: cavalli m. Chem Biodivers. 2016 Jun;13(6):762-75. doi: 10.1002/cbdv.201500241. Epub 2016 Jun 2. Chem Biodivers. 2016. PMID: 27144301

2

Synthesis and activity studies of analogues of the rat selective toxicant norbormide.

Rennison D, Bova S, Cavalli M, Ricchelli F, Zulian A, Hopkins B, Brimble MA. Rennison D, et al. Among authors: cavalli m. Bioorg Med Chem. 2007 Apr 15;15(8):2963-74. doi: 10.1016/j.bmc.2007.02.012. Epub 2007 Feb 11. Bioorg Med Chem. 2007. PMID: 17321141

3

Assessing the molecular basis for rat-selective induction of the mitochondrial permeability transition by norbormide.

Zulian A, Petronilli V, Bova S, Dabbeni-Sala F, Cargnelli G, Cavalli M, Rennison D, Stäb J, Laita O, Lee DJ, Brimble MA, Hopkins B, Bernardi P, Ricchelli F. Zulian A, et al. Among authors: cavalli m. Biochim Biophys Acta. 2007 Jul;1767(7):980-8. doi: 10.1016/j.bbabio.2007.04.002. Epub 2007 Apr 14. Biochim Biophys Acta. 2007. PMID: 17509521 Free article.

4

Design and synthesis of prodrugs of the rat selective toxicant norbormide.

Rennison D, Laita O, Bova S, Cavalli M, Hopkins B, Linthicum DS, Brimble MA. Rennison D, et al. Among authors: cavalli m. Bioorg Med Chem. 2012 Jul 1;20(13):3997-4011. doi: 10.1016/j.bmc.2012.05.014. Epub 2012 May 15. Bioorg Med Chem. 2012. PMID: 22658693

5

Prodrugs of N-dicarboximide derivatives of the rat selective toxicant norbormide.

Rennison D, Laita O, Conole D, Jay-Smith M, Knauf J, Bova S, Cavalli M, Hopkins B, Linthicum DS, Brimble MA. Rennison D, et al. Among authors: cavalli m. Bioorg Med Chem. 2013 Sep 15;21(18):5886-99. doi: 10.1016/j.bmc.2013.06.071. Epub 2013 Jul 10. Bioorg Med Chem. 2013. PMID: 23920483

6

Distribution of the vasoconstrictor and vasorelaxant effects of norbormide along the vascular tree of the rat.

Cavalli M, Omiciuolo L, Cargnelli G, Cima L, Hopkins B, Bova S. Cavalli M, et al. Life Sci. 2004 Sep 17;75(18):2157-65. doi: 10.1016/j.lfs.2004.04.022. Life Sci. 2004. PMID: 15325842

7

Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile.

Bova S, Saponara S, Rampa A, Gobbi S, Cima L, Fusi F, Sgaragli G, Cavalli M, de los Rios C, Striessnig J, Bisi A. Bova S, et al. Among authors: cavalli m. J Med Chem. 2009 Mar 12;52(5):1259-62. doi: 10.1021/jm801589x. J Med Chem. 2009. PMID: 19203272

8

Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles.

Bova S, Cavalli M, Cima L, Luciani S, Saponara S, Sgaragli G, Cargnelli G, Fusi F. Bova S, et al. Among authors: cavalli m. Eur J Pharmacol. 2003 Jun 6;470(3):185-91. doi: 10.1016/s0014-2999(03)01797-7. Eur J Pharmacol. 2003. PMID: 12798957

9

Effects of commonly used protein kinase inhibitors on vascular contraction and L-type Ca(2+) current.

Saponara S, Fusi F, Sgaragli G, Cavalli M, Hopkins B, Bova S. Saponara S, et al. Among authors: cavalli m. Biochem Pharmacol. 2012 Oct 15;84(8):1055-61. doi: 10.1016/j.bcp.2012.07.025. Epub 2012 Jul 31. Biochem Pharmacol. 2012. PMID: 22884855

10

Characterization of intrinsic sympathomimetic activity of carteolol in rat cardiovascular preparations.

Floreani M, Froldi G, Cavalli M, Bova S, Giron MC, Varani K, Gessi S, Borea PA, Dorigo MT, Dorigo P. Floreani M, et al. Among authors: cavalli m. J Pharmacol Sci. 2004 May;95(1):115-23. doi: 10.1254/jphs.95.115. J Pharmacol Sci. 2004. PMID: 15153658 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters